It Takes Two to Tango, Part II: Synthesis of A-Ring Functionalised Quinones Containing Two Redox-Active Centres with Antitumour Activities

In 2021, our research group published the prominent anticancer activity achieved through the successful combination of two redox centres (ortho-quinone/para-quinone or quinone/selenium-containing triazole) through a copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction. The combination of two naphthoquinoidal substrates towards a synergetic product was indicated, but not fully explored. Herein, we report the synthesis of 15 new quinone-based derivatives prepared from click chemistry reactions and their subsequent evaluation against nine cancer cell lines and the murine fibroblast line L929. Our strategy was based on the modification of the A-ring of para-naphthoquinones and subsequent conjugation with different ortho-quinoidal moieties. As anticipated, our study identified several compounds with IC50 values below 0.5 µM in tumour cell lines. Some of the compounds described here also exhibited an excellent selectivity index and low cytotoxicity on L929, the control cell line. The antitumour evaluation of the compounds separately and in their conjugated form proved that the activity is strongly enhanced in the derivatives containing two redox centres. Thus, our study confirms the efficiency of using A-ring functionalized para-quinones coupled with ortho-quinones to obtain a diverse range of two redox centre compounds with potential applications against cancer cell lines. Here as well, it literally takes two for an efficient tango!

[1]  K. Al-adilee,et al.  Synthesis and spectral characterization of some metal complexes with new heterocyclic azo imidazole dye ligand and study biological activity as anticancer , 2022, Journal of Molecular Structure.

[2]  S. Tekin,et al.  Synthesis, in vitro, and in silico studies of novel poly‐heterocyclic compounds bearing pyridine and furan moieties as potential anticancer agents , 2022, Journal of Molecular Structure.

[3]  N. Jaradat,et al.  Synthesis of novel isoxazole–carboxamide derivatives as promising agents for melanoma and targeted nano-emulgel conjugate for improved cellular permeability , 2022, BMC Chemistry.

[4]  S. Tabrez,et al.  Targeting PI3K/Akt/mTOR Pathway by Different Flavonoids: A Cancer Chemopreventive Approach , 2021, International Journal of Molecular Sciences.

[5]  C. Jacob,et al.  It takes two to tango: synthesis of cytotoxic quinones containing two redox active centers with potential antitumor activity. , 2021, RSC medicinal chemistry.

[6]  Ajmal Ahmad,et al.  Flavonoids and PI3K/Akt/mTOR signaling cascade: A potential crosstalk in anticancer treatment. , 2021, Current medicinal chemistry.

[7]  Xiangdong Hu,et al.  Enantioselective Total Synthesis of ( - )-Spiroxins A, C and D. , 2021, Angewandte Chemie.

[8]  J. Čapek,et al.  2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease. , 2020, European journal of medicinal chemistry.

[9]  Om P. S. Patel,et al.  Antimalarial application of quinones: A recent update. , 2020, European journal of medicinal chemistry.

[10]  R. Dusi,et al.  Residual Larvicidal Activity of Quinones against Aedes aegypti , 2020, Molecules.

[11]  Xianfu Shen,et al.  Iron-catalyzed regioselective alkylation of 1,4-quinones and coumarins with functionalized alkyl bromides. , 2020, Organic & biomolecular chemistry.

[12]  C. Jacob,et al.  Synthesis of quinones with highlighted biological applications: A critical update on the strategies towards bioactive compounds with emphasis on lapachones. , 2019, European journal of medicinal chemistry.

[13]  M. H. Araujo,et al.  Beyond copper-catalyzed azide-alkyne 1,3-dipolar cycloaddition: Synthesis and mechanism insights , 2019, Tetrahedron.

[14]  C. Jacob,et al.  Ruthenium(II)-Catalyzed C-H Alkenylation of Quinones: Diversity-Oriented Strategy for Trypanocidal Compounds , 2019, European Journal of Organic Chemistry.

[15]  C. Jacob,et al.  Ruthenium-catalyzed C-H oxygenation of quinones by weak O-coordination for potent trypanocidal agents. , 2018, Chemical communications.

[16]  Yang Xie,et al.  Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis , 2018, British Journal of Cancer.

[17]  I. Namboothiri,et al.  Quinonoid compounds via reactions of lawsone and 2-aminonaphthoquinone with α-bromonitroalkenes and nitroallylic acetates: Structural diversity by C-ring modification and cytotoxic evaluation against cancer cells. , 2018, European journal of medicinal chemistry.

[18]  M. Goulart,et al.  Direct sequential C-H iodination/organoyl-thiolation for the benzenoid A-ring modification of quinonoid deactivated systems: a new protocol for potent trypanocidal quinones. , 2018, Organic & biomolecular chemistry.

[19]  C. Jacob,et al.  Synthesis of Selenium-Quinone Hybrid Compounds with Potential Antitumor Activity via Rh-Catalyzed C-H Bond Activation and Click Reactions , 2017, Molecules.

[20]  M. Vendrell,et al.  On the synthesis of quinone-based BODIPY hybrids: New insights on antitumor activity and mechanism of action in cancer cells. , 2017, Bioorganic & medicinal chemistry letters.

[21]  H. Hussain,et al.  Lapachol and lapachone analogs: a journey of two decades of patent research(1997-2016) , 2017, Expert opinion on therapeutic patents.

[22]  I. Namboothiri,et al.  Synthesis of Quinone‐Based N‐Sulfonyl‐1,2,3‐triazoles: Chemical Reactivity of Rh(II) Azavinyl Carbenes and Antitumor Activity , 2017 .

[23]  M. Mazzanti,et al.  Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds. , 2016, Drug discovery today.

[24]  Sungwoo Hong,et al.  Identification of β-Lapachone Analogs as Novel MALT1 Inhibitors To Treat an Aggressive Subtype of Diffuse Large B-Cell Lymphoma. , 2015, Journal of medicinal chemistry.

[25]  C. Nantasenamat,et al.  Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies. , 2015, European journal of medicinal chemistry.

[26]  D. Ramos,et al.  On the search for potential antimycobacterial drugs: synthesis of naphthoquinoidal, phenazinic and 1,2,3-triazolic compounds and evaluation against mycobacterium tuberculosis , 2015 .

[27]  G. Sheldrick SHELXT – Integrated space-group and crystal-structure determination , 2015, Acta crystallographica. Section A, Foundations and advances.

[28]  R. S. Menna-Barreto,et al.  Anti-Trypanosoma cruzi compounds: our contribution for the evaluation and insights on the mode of action of naphthoquinones and derivatives , 2014 .

[29]  S. Shrivastava,et al.  Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones. , 2014, European journal of medicinal chemistry.

[30]  Weixian Xi,et al.  Click Chemistry in Materials Science , 2014 .

[31]  J. Gilloteaux,et al.  Synergistic Antitumor Cytotoxic Actions of Ascorbate and Menadione on Human Prostate (DU145) Cancer Cells In Vitro: Nucleus and Other Injuries Preceding Cell Death by Autoschizis , 2014, Ultrastructural pathology.

[32]  S. Nor,et al.  Synthesis of New Cytotoxic Aminoanthraquinone Derivatives via Nucleophilic Substitution Reactions , 2013, Molecules.

[33]  Wenhe Zhu,et al.  Anticancer activity and mechanism of juglone on human cervical carcinoma HeLa cells. , 2012, Canadian journal of physiology and pharmacology.

[34]  V. Pore,et al.  Click chemistry: 1,2,3-triazoles as pharmacophores. , 2011, Chemistry, an Asian journal.

[35]  B. Cavalcanti,et al.  Quinonoid and phenazine compounds: synthesis and evaluation against H37Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis. , 2011, European journal of medicinal chemistry.

[36]  L. Costa-Lotufo,et al.  Synthesis and evaluation of quinonoid compounds against tumor cell lines. , 2011, European journal of medicinal chemistry.

[37]  L. Costa-Lotufo,et al.  Cytotoxic activity of naphthoquinones with special emphasis on juglone and its 5-O-methyl derivative. , 2010, Chemico-biological interactions.

[38]  C. K. Andrade,et al.  3-arylamino and 3-alkoxy-nor-beta-lapachone derivatives: synthesis and cytotoxicity against cancer cell lines. , 2010, Journal of medicinal chemistry.

[39]  Richard J. Gildea,et al.  OLEX2: a complete structure solution, refinement and analysis program , 2009 .

[40]  M. Heinrich,et al.  Red Lapacho (Tabebuia impetiginosa)--a global ethnopharmacological commodity? , 2009, Journal of ethnopharmacology.

[41]  V. Ferreira,et al.  Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi. , 2008, European journal of medicinal chemistry.

[42]  G. Sheldrick A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[43]  R. S. Silva,et al.  Synthesis of naphthofuranquinones with activity against Trypanosoma cruzi. , 2006, European journal of medicinal chemistry.

[44]  Ken-ichi Fujita,et al.  Cytochrome P450 and anticancer drugs. , 2006, Current drug metabolism.

[45]  A. Sparreboom,et al.  Recent advances in pharmacogenetic approaches to anticancer drug development , 2004 .

[46]  C. Sangma,et al.  Potent antitumor activity of synthetic 1,2-Naphthoquinones and 1,4-Naphthoquinones. , 2003, Bioorganic & medicinal chemistry.

[47]  Qian Wang,et al.  Bioconjugation by copper(I)-catalyzed azide-alkyne [3 + 2] cycloaddition. , 2003, Journal of the American Chemical Society.

[48]  Xiangao Sun,et al.  Selective killing of cancer cells by β-lapachone: Direct checkpoint activation as a strategy against cancer , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Bolton,et al.  Role of quinones in toxicology. , 2000, Chemical research in toxicology.

[50]  D. Siegel,et al.  NAD(P)H:Quinone Oxidoreductase Activity Is the Principal Determinant of b -Lapachone Cytotoxicity* , 2000 .

[51]  T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[52]  A. Samy,et al.  Synthesis, characterization of new heterocyclic compound: pyrazolyl hydrazino quinoxaline derivative: 3-[5-(hydroxy1methyl)-1-phenylpyrazol-3-yl]-2-[2, 4, 5-trimethoxybenzylidine] hydrazonyl-quinoxaline of potent antimicrobial, antioxidant, antiviral, and antitumor activity , 2022, Journal of Molecular Structure.